GSDME and acute kidney injury: Mechanistically, active caspase‐3, which is activated after I/R‐ or cisplatin‐treatment, cleaves GSDME and consequently contributes to I/R‐ or cisplatin‐induced AKI by triggering GSDME‐mediated pyroptosis in TECs.